| Literature DB >> 33526711 |
Sven E Niklander1,2, Hannah L Crane1, Lav Darda1, Daniel W Lambert1, Keith D Hunter3,4.
Abstract
There is compelling evidence that senescent cells, through the senescence-associated secretory phenotype (SASP), can promote malignant transformation and invasion. Interleukin-1 (IL-1) is a key mediator of this cytokine network, but the control of its activity in the senescence programme has not been elucidated. IL-1 signalling is regulated by IL-1RA, which has four variants. Here, we show that expression of intracellular IL-1RA type 1 (icIL-1RA1), which competitively inhibits binding of IL-1 to its receptor, is progressively lost during oral carcinogenesis ex vivo and that the pattern of expression is associated with keratinocyte replicative fate in vitro We demonstrate that icIL-1RA1 is an important regulator of the SASP in mortal cells, as CRISPR/Cas9-mediated icIL-1RA1 knockdown in normal and mortal dysplastic oral keratinocytes is followed by increased IL-6 and IL-8 secretion, and rapid senescence following release from RhoA-activated kinase inhibition. Thus, we suggest that downregulation of icIL-1RA1 in early stages of the carcinogenesis process can enable the development of a premature and deregulated SASP, creating a pro-inflammatory state in which cancer is more likely to arise.Entities:
Keywords: Head and neck cancer; IL-1RA; Interleukin 1 receptor antagonist; SASP; Senescence
Mesh:
Substances:
Year: 2021 PMID: 33526711 DOI: 10.1242/jcs.252080
Source DB: PubMed Journal: J Cell Sci ISSN: 0021-9533 Impact factor: 5.285